Screening for neurodevelopmental disorders in children with congenital heart disease
Official title: Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease
Run by University Hospital, Montpellier · NCT06431269 · Data updated 2026-11-12
This study tests if regular check-ups can help find neurodevelopmental disorders in young children with congenital heart disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Year to 5 Years |
| Sex | All |
| Enrollment | 270 (estimated) |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 3 sites (Montpellier and 2 other locations) |
| Status | Recruiting |
| Started | May 31, 2024 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | September 25, 2025 |
| Trial ID | NCT06431269 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 1 to 5 years with stable congenital heart disease and no prior diagnosis of neurodevelopmental disorders.
✕Probably not a fit
Patients with genetic or poly-malformative syndromes requiring specialized neurodevelopmental care may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the feasibility and efficiency of screening for neurodevelopmental disorders (NDD) in children aged 1 to 5 years who have congenital heart disease (CHD). An Advanced Practice Nurse (APN) will conduct systematic screenings during routine cardiac follow-ups. If NDD is suspected, children will be referred to a neuropsychologist for further evaluation and management. The study addresses the gap in medical resources for early NDD detection in this vulnerable population.
Why it matters
Potential benefit: If successful, this approach could lead to earlier diagnosis and management of neurodevelopmental disorders in children with congenital heart disease, improving their long-term quality of life.
How similar studies have gone: While similar approaches have been explored, this specific method of screening by an Advanced Practice Nurse in this population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Congenital heart disease with stable status defined by last operation \>3 months, no cardiac decompensation in the last 3 months, no planned surgery within 6 months after the inclusion * Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life, * Patient aged 1 to 5 years. * No previous medical diagnosis of NDD * Parental or legal guardian's consent. * Social security affiliation (for France only) Exclusion Criteria: * Patients with a genetic or poly-malformative syndrome with known neurological impairment. * Neurodevelopmental disorder already known/treated * Neurodevelopmental status evaluation within the last 6 months.
Where it's running
-
University Hospitial of Montpellier
Montpellier, France Recruiting -
Institut Marin Saint-Pierre
Palavas-les-Flots, France Not yet recruiting -
CHU Bordeaux Haut-Lévêque
Pessac, France Not yet recruiting
Study contacts
- Study coordinator: Marie VINCENTI, MD
- Email: m-vincenti@chu-montpellier.fr
- Phone: 04 67 33 66 39
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions
This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Melillo Method for kids with behavior and learning challenges
This pilot test will see if the Melillo Method can be feasibly delivered in two Illinois schools to help kids aged 8 and up who have behavioral and learning difficulties.
-
Understanding how sensory brain signals vary in people with and without neurodevelopmental disorders
This study tests whether people with neurodevelopmental disorders show more variation in brain responses to sensory stimulation than people without these disorders.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.